Titan Pharmaceuticals
TTNP
#10567
Rank
NZ$10.43 M
Marketcap
NZ$7.85
Share price
-3.76%
Change (1 day)
18.43%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.47. In 2023 the company made an earnings per share (EPS) of NZ-$12.61 an increase over its 2022 EPS that were of NZ-$25.86.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.61-51.22%
2022NZ-$25.86-15.61%
2021NZ-$30.64-81.37%
2020NZ-$164.43-77.52%
2019NZ-$731.61-56.32%
2018NZ-$1,675-59.51%
2017NZ-$4,137-371.81%
2016NZ$1,522-144.35%
2015NZ-$3,432300%
2014NZ-$857.92-121.54%
2013NZ$3,983-151.38%
2012NZ-$7,752-11.54%
2011NZ-$8,763188.89%
2010NZ-$3,033-10%
2009NZ-$3,370
2007NZ-$13,819-2.38%
2006NZ-$14,156-39.13%
2005NZ-$23,256-16.87%
2004NZ-$27,974-22.43%
2003NZ-$36,0634.9%
2002NZ-$34,37861.9%
2001NZ-$21,233-13.7%
2000NZ-$24,60465.01%
1999NZ-$14,911-35.87%
1998NZ-$23,252-1824.71%
1997NZ$1,348-102.4%
1996NZ-$56,285

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.87-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.95-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.42-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.57-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.43-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.62-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA